SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-20-035331
Filing Date
2020-02-13
Accepted
2020-02-13 15:09:35
Documents
1
Group Members
DELAWARE SMID CAP GROWTH FUND, A SERIES OF DELAWARE GROUP EQUITY FUNDS IVMACQUARIE BANK LTDMACQUARIE FUNDS MANAGEMENT HONG KONG LTDMACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUSTMACQUARIE INVESTMENT MANAGEMENT HOLDINGS INC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d889906dsc13ga.htm SC 13G/A 140066
  Complete submission text file 0001193125-20-035331.txt   141929
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Subject) CIK: 0001267565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88843 | Film No.: 20609736
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 MARTIN PLACE SYDNEY, NSW 2000 C3 2000
Business Address 50 MARTIN PLACE SYDNEY, NSW 2000 C3 2000 212.231.1000
MACQUARIE GROUP LTD (Filed by) CIK: 0001418333 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: SC 13G/A